vs
Guardant Health, Inc.（GH）与Ranger Energy Services, Inc.（RNGR）财务数据对比。点击上方公司名可切换其他公司
Guardant Health, Inc.的季度营收约是Ranger Energy Services, Inc.的2.0倍（$281.3M vs $142.2M），Ranger Energy Services, Inc.净利率更高（2.3% vs -45.7%，领先47.9%），Guardant Health, Inc.同比增速更快（39.4% vs -0.6%），Ranger Energy Services, Inc.自由现金流更多（$17.1M vs $-54.2M），过去两年Guardant Health, Inc.的营收复合增速更高（29.2% vs 1.9%）
Guardant Health, Inc.是总部位于美国加利福尼亚州帕洛阿尔托的生物技术企业，由Helmy Eltoukhy与AmirAli Talasaz联合创立，目前二人共同出任公司首席执行官，统筹公司战略规划与日常运营管理工作。
Ranger Energy Services是北美领先的陆上油田服务提供商，为上游油气运营商提供完井、修井、钻机作业及产能优化等全套解决方案，业务主要覆盖美国本土的页岩和致密资源开采作业区。
GH vs RNGR — 直观对比
营收规模更大
GH
是对方的2.0倍
$142.2M
营收增速更快
GH
高出40.0%
-0.6%
净利率更高
RNGR
高出47.9%
-45.7%
自由现金流更多
RNGR
多$71.3M
$-54.2M
两年增速更快
GH
近两年复合增速
1.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $281.3M | $142.2M |
| 净利润 | $-128.5M | $3.2M |
| 毛利率 | 64.6% | — |
| 营业利润率 | -43.0% | 2.3% |
| 净利率 | -45.7% | 2.3% |
| 营收同比 | 39.4% | -0.6% |
| 净利润同比 | -15.8% | -44.8% |
| 每股收益（稀释后） | $-1.01 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GHRNGR
| Q4 25 | $281.3M | $142.2M | ||
| Q3 25 | $265.2M | $128.9M | ||
| Q2 25 | $232.1M | $140.6M | ||
| Q1 25 | $203.5M | $135.2M | ||
| Q4 24 | $201.8M | $143.1M | ||
| Q3 24 | $191.5M | $153.0M | ||
| Q2 24 | $177.2M | $138.1M | ||
| Q1 24 | $168.5M | $136.9M |
净利润GHRNGR
| Q4 25 | $-128.5M | $3.2M | ||
| Q3 25 | $-92.7M | $1.2M | ||
| Q2 25 | $-99.9M | $7.3M | ||
| Q1 25 | $-95.2M | $600.0K | ||
| Q4 24 | $-111.0M | $5.8M | ||
| Q3 24 | $-107.8M | $8.7M | ||
| Q2 24 | $-102.6M | $4.7M | ||
| Q1 24 | $-115.0M | $-800.0K |
毛利率GHRNGR
| Q4 25 | 64.6% | — | ||
| Q3 25 | 64.7% | — | ||
| Q2 25 | 65.0% | — | ||
| Q1 25 | 63.3% | — | ||
| Q4 24 | 61.6% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 59.1% | — | ||
| Q1 24 | 61.2% | — |
营业利润率GHRNGR
| Q4 25 | -43.0% | 2.3% | ||
| Q3 25 | -37.3% | 2.0% | ||
| Q2 25 | -45.9% | 6.1% | ||
| Q1 25 | -54.6% | 0.7% | ||
| Q4 24 | -62.4% | 6.2% | ||
| Q3 24 | -61.3% | 8.4% | ||
| Q2 24 | -56.8% | 5.3% | ||
| Q1 24 | -59.2% | -0.4% |
净利率GHRNGR
| Q4 25 | -45.7% | 2.3% | ||
| Q3 25 | -35.0% | 0.9% | ||
| Q2 25 | -43.0% | 5.2% | ||
| Q1 25 | -46.8% | 0.4% | ||
| Q4 24 | -55.0% | 4.1% | ||
| Q3 24 | -56.3% | 5.7% | ||
| Q2 24 | -57.9% | 3.4% | ||
| Q1 24 | -68.2% | -0.6% |
每股收益（稀释后）GHRNGR
| Q4 25 | $-1.01 | $0.14 | ||
| Q3 25 | $-0.74 | $0.05 | ||
| Q2 25 | $-0.80 | $0.32 | ||
| Q1 25 | $-0.77 | $0.03 | ||
| Q4 24 | $-0.90 | $0.24 | ||
| Q3 24 | $-0.88 | $0.39 | ||
| Q2 24 | $-0.84 | $0.21 | ||
| Q1 24 | $-0.94 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $378.2M | $10.3M |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $-99.3M | $300.1M |
| 总资产 | $2.0B | $419.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GHRNGR
| Q4 25 | $378.2M | $10.3M | ||
| Q3 25 | $580.0M | $45.2M | ||
| Q2 25 | $629.1M | $48.9M | ||
| Q1 25 | $698.6M | $40.3M | ||
| Q4 24 | $525.5M | $40.9M | ||
| Q3 24 | $585.0M | $14.8M | ||
| Q2 24 | $933.7M | $8.7M | ||
| Q1 24 | $1.0B | $11.1M |
总债务GHRNGR
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益GHRNGR
| Q4 25 | $-99.3M | $300.1M | ||
| Q3 25 | $-354.5M | $270.0M | ||
| Q2 25 | $-305.5M | $276.9M | ||
| Q1 25 | $-250.8M | $272.6M | ||
| Q4 24 | $-139.6M | $273.8M | ||
| Q3 24 | $-60.1M | $267.6M | ||
| Q2 24 | $-1.6M | $260.5M | ||
| Q1 24 | $68.3M | $261.7M |
总资产GHRNGR
| Q4 25 | $2.0B | $419.3M | ||
| Q3 25 | $1.3B | $372.8M | ||
| Q2 25 | $1.3B | $381.7M | ||
| Q1 25 | $1.3B | $376.5M | ||
| Q4 24 | $1.5B | $381.6M | ||
| Q3 24 | $1.5B | $373.9M | ||
| Q2 24 | $1.6B | $359.6M | ||
| Q1 24 | $1.7B | $355.5M |
负债/权益比GHRNGR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-26.4M | $24.1M |
| 自由现金流经营现金流 - 资本支出 | $-54.2M | $17.1M |
| 自由现金流率自由现金流/营收 | -19.3% | 12.0% |
| 资本支出强度资本支出/营收 | 9.9% | 4.9% |
| 现金转化率经营现金流/净利润 | — | 7.53× |
| 过去12个月自由现金流最近4个季度 | $-233.1M | $42.9M |
8季度趋势，按日历期对齐
经营现金流GHRNGR
| Q4 25 | $-26.4M | $24.1M | ||
| Q3 25 | $-35.4M | $13.6M | ||
| Q2 25 | $-60.3M | $20.7M | ||
| Q1 25 | $-62.7M | $10.6M | ||
| Q4 24 | $-64.5M | $32.7M | ||
| Q3 24 | $-51.1M | $17.7M | ||
| Q2 24 | $-94.0M | $22.1M | ||
| Q1 24 | $-30.3M | $12.0M |
自由现金流GHRNGR
| Q4 25 | $-54.2M | $17.1M | ||
| Q3 25 | $-45.8M | $8.0M | ||
| Q2 25 | $-65.9M | $14.4M | ||
| Q1 25 | $-67.1M | $3.4M | ||
| Q4 24 | $-83.4M | $27.3M | ||
| Q3 24 | $-55.3M | $10.8M | ||
| Q2 24 | $-99.1M | $6.8M | ||
| Q1 24 | $-37.2M | $5.5M |
自由现金流率GHRNGR
| Q4 25 | -19.3% | 12.0% | ||
| Q3 25 | -17.3% | 6.2% | ||
| Q2 25 | -28.4% | 10.2% | ||
| Q1 25 | -33.0% | 2.5% | ||
| Q4 24 | -41.3% | 19.1% | ||
| Q3 24 | -28.9% | 7.1% | ||
| Q2 24 | -55.9% | 4.9% | ||
| Q1 24 | -22.1% | 4.0% |
资本支出强度GHRNGR
| Q4 25 | 9.9% | 4.9% | ||
| Q3 25 | 3.9% | 4.3% | ||
| Q2 25 | 2.4% | 4.5% | ||
| Q1 25 | 2.2% | 5.3% | ||
| Q4 24 | 9.4% | 3.8% | ||
| Q3 24 | 2.2% | 4.5% | ||
| Q2 24 | 2.9% | 11.1% | ||
| Q1 24 | 4.1% | 4.7% |
现金转化率GHRNGR
| Q4 25 | — | 7.53× | ||
| Q3 25 | — | 11.33× | ||
| Q2 25 | — | 2.84× | ||
| Q1 25 | — | 17.67× | ||
| Q4 24 | — | 5.64× | ||
| Q3 24 | — | 2.03× | ||
| Q2 24 | — | 4.70× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GH
| Oncology | $189.9M | 68% |
| Biopharma Data | $54.0M | 19% |
| Screening | $35.1M | 12% |
| Licensing Other | $2.2M | 1% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
